Nibec operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nibec with three other
pharmaceutical manufacturers in Asia:
AnyGen Co Ltd
sales of 4.18 billion Korean Won [US$3.94 million]
Phong Phu Pharmaceutical JSC
(120.90 billion Dong [US$5.32 million]
Gujarat Themis Biosyn Limited
based in India
(326.25 million Indian Rupees [US$5.13 million]
Nibec reported sales of 4.80 billion Korean Won (US$4.53 million)
December of 2016.
increase of 15.1%
versus 2015, when the company's sales were 4.17 billion Korean Won.